HANNAH VAUGHAN: Open Payments
NPI 1043724420 · ENID, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,951 in 114 payments from 11 companies in 2025. Trend: 2023 $2,991 · 2024 $2,250 · 2025 $1,951
Food & beverage: $1,951
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 24 | $613 |
| GlaxoSmithKline, LLC. | 35 | $490 |
| Insmed, Inc. | 20 | $332 |
| Viatris Specialty LLC | 15 | $165 |
| GENZYME CORPORATION | 8 | $140 |
| Grifols USA, LLC | 2 | $49 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $46 |
| Regeneron Healthcare Solutions, Inc. | 2 | $41 |
| Verona Pharma, Inc. | 2 | $31 |
| Electromed, Inc. | 3 | $25 |
Products named: Arikayce, TRELEGY ELLIPTA, AIRSUPRA, NUCALA, DUPIXENT, YUPELRI, TEZSPIRE, FASENRA.
Industry payments across OK — which companies pay providers there.
